RepliCel Life Sciences Inc. today announced the appointment of industry specialist, R. Lee Buckler, to the position of Vice President, Business and Corporate Development.
"I am excited to have the opportunity to join RepliCel
at such a pivotal time for the Company," said Lee Buckler
team has built a solid portfolio of products assembled around a cohesive platform that is now about to launch several concurrent trials with relatively near-term clinical readouts.
I look forward to establishing new collaborations, deals and non-dilutive funding sources in a way which consistently adds value to the company and its core assets.
I believe RepliCel's
technology platform represents a significant opportunity to establish a leadership role in the regenerative medicine sector."
"We are delighted to have Lee join the RepliCel team at a time when the development of our clinical pipeline warrants focus on larger corporate licensing transactions and external collaborations," stated David Hall, CEO RepliCel.
"Lee is a well-established and respected member of the regenerative medicine industry with broad industry contacts that will support our concerted licensing and business development efforts already initiated by our technology transfer and licensing agreement with the Shiseido Company.
Attracting a professional of Lee's calibre is further validation of the Company's business plan.
We are fortunate to be able to attract someone of Lee's industry stature."
Lee has a Bachelors of Education and a law degree from the University of British Columbia.
After a judicial clerkship, Lee practiced commercial litigation at the Vancouver law firm Edwards, Kenny and Bray.
Since 2000, Lee has been an executive in the cell therapy industry first spending six years in the Stem Cell Technologies group of companies with Malachite Management and then over two years with Progenitor Cell Therapy (PCT).
In 2008, Lee started the Cell Therapy Group (CTG), a business development consultancy focused exclusively on the cell therapy industry.
While at Malachite, Lee founded the digital news aggregation service Cell Therapy News and was Executive Director of the International Society for Cellular Therapy (ISCT).
Upon launching CTG
created Cell Therapy Blog and developed significant followings related to cell therapy on social media platforms such as Twitter and LinkedIn
While at PCT, under the guidance of the ISCT President, Lee founded and served as the inaugural Chair of ISCT's Cell Therapy Commercialization Committee (2006-9) and is currently serving as the co-chair of the Alliance for Regenerative Medicine's Communications and Education Committee.
is a frequently invited speaker at industry conferences and an oft-quoted commentator on industry events.
has published numerous articles in peer-reviewed journals and trade publications.
He is on the Editorial Advisory Board for the journals, Regenerative Medicine and BioProcess International.
Lee serves on the advisory board for several companies and annual industry events.